The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):419-21. doi: 10.1097/HJR.0b013e32801101aa.

Abstract

Background and design: The effect of the cholesteryl ester transfer protein (CETP) I405V polymorphism on lipid levels, atherosclerosis and myocardial infarction (MI) was examined in 6421 participants from the Rotterdam Study.

Methods: Quantitative outcomes were studied with linear models; Cox models were used to assess MI risk.

Results: High-density lipoprotein cholesterol (HDL) increased by 0.06 [95% confidence interval (CI): 0.03, 0.09] mmol/l in VV carriers. The V allele was further associated with decreased MI risk in men [hazard ratio (95% confidence interval)=0.57 (0.45, 0.73), VV versus II] (Ptrend=0.02).

Conclusion: This study provides additional evidence for the association of CETP with HDL levels and suggests that CETP is an atherogenic protein increasing the risk of MI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / blood
  • Atherosclerosis / complications
  • Atherosclerosis / genetics
  • Cholesterol Ester Transfer Proteins / genetics*
  • Female
  • Follow-Up Studies
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Incidence
  • Linear Models
  • Lipoproteins, HDL / blood*
  • Male
  • Middle Aged
  • Myocardial Infarction / blood*
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / genetics*
  • Netherlands / epidemiology
  • Polymorphism, Genetic*
  • Population Surveillance
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Time Factors
  • Up-Regulation

Substances

  • Cholesterol Ester Transfer Proteins
  • Lipoproteins, HDL